Five awards funded:

  • Modulation of Early Inflammatory Response to Prevent Muscle Degeneration in Massive Rotator Cuff Tears
    • Claudius Jarrett, MD, Assistant Professor, Emory University. School of Medicine-Orthopaedics ($25,000)
    • Johnna Temenoff, PhD, Associate Professor, Georgia Technical Institute and Emory University-Biomedical Engineering ($25,000)
  • DNA-barcoded peptide-MHC tetramers for profiling antigen-specific T cells
    • John Altman, PhD, Associate Professor, Emory University-Department of Microbiology and Immunology ($25,000)
    • Gabe Kwong, PhD, Assistant Professor, Georgia Technical Institute and Emory University-Biomedical Engineering ($25,000)
  • Development of a novel immune enhancing microparticle-conjugated RIG-I agonist
    • Mehul Suthar, PhD, Assistant Professor, Emory University, School of Medicine-Pediatrics ($30,000)
    • Krishnendu Roy, PhD, Professor, Georgia Technical Institute and Emory University-Biomedical Engineering ($20,000)
  • Engineered mesenchymal stromal cells for enhancing lymphangiogenesis as a therapeutic for osteoarthritis
    • Nick Willett, PhD, Emory University, School of Medicine-Orthopaedics
    • Rebecca Levit, MD, Assistant Profesor, Division of Cardiology, Emory University ($21,062 Emory)
    • J. Brandon Dixon, PhD, Associate Professor, Georgia Institute of Technology-Mechanical Engineering, Bioengineering and Bioscience, Biomedical Engineering ($28,938)
  • Human mesenchymal stem cell-driven immunomodulation for enhanced engraftment of human pluripotent stem cell derived cardiomyocytes
    • Young-sup Yoon, MD, PhD, Profesor, Emory University, School of Medicine-Stem Cell Biology ($25,000)
    • Satish Kumar, PhD, Professor, Georgia Institute of Technology-School of Materials Science and Engineering ($25,000)

Upcoming Events

    View All Events

    Funding News

    Community

    Georgia CTSA Pilot Grants Program

    For over 10 years the Georgia CTSA Pilot Grants program has distributed grant funding to support one to two year pilot projects that advance and transform laboratory, clinic, and community observations into interventions that improve public and...

    Discovery

    CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

    A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....